<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

2 min read

CAR-TCR, August 29 - September 1

CAR-TCR, August 29 - September 1

Booth: #J106

Date: August 29 - September 1, 2023

Location: Hynes Convention Center in Boston, MA, USA - Get directions

Event website: https://car-tcr-summit.com/ 


Join us for an important Panel on CMC Cell Therapy Strategies

Our Sr. Director of Process Development, Patricia Bettinger, will be participating in the panel discussion on Developing a Robust CMC Strategy during the event on August 31 at 12:30pm, along with leaders from cell therapy development companies to discuss challenges in development and analytics, clinical to commercial planning, comparability, and more! 

Request a meeting

Would you like to talk with one of our team members? Interested in learning more about our global network and capabilities? Click the button below or email one of our attending representatives at the event to set up a meeting.


You can also reach out directly to our experts attending the show

Grace Kim
Sr. VP, Business Development
Email  me
Paul DiCandeloro
Sr. Director, Business Development
Email  me
Patricia Bettinger
Sr. Director, Process Development
Email  me

Explore our new AAV & LVV Platforms

BravoAAV™ and ProntoLVV™ are end-to-end platforms offering a proprietary GOI backbone and plug-and-play templates for any project. Our services include proprietary plasmids, in-house analytical panels, master cell banks, pre-qualified processes and fill and finish services.  

Learn about our cell and gene therapy services 

Cell Therapy Production and Manufacturing

AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.  

Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. 

Learn more about our overall cell therapy offering 


Plasmid DNA (pDNA) Materials 

To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing. 

Learn more about our Plasmid offering


Viral Vector Production and Manufacturing 

AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products. 

Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house. 

Discover more about our viral vector services 


Fill out the form below to request a meeting during the event


ESGCT 30th Annual Congress, October 24-27

ESGCT 30th Annual Congress, October 24-27

CPHI Barcelona, October 24-26

CPHI Barcelona, October 24-26

BioJapan, October 11-13

BioJapan, October 11-13